Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery
NCT07155057
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Dry Eye Disease (DED)
Interventions
DEVICE:
Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML
Sponsor
Vance Thompson Vision